Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,923,078
in 11 filings, $11.2M under 10b5-1 plans

Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MIGNONE ROBERTO −$14.4M Director sold 100% of stake
  2. Francis Richard D −$10.6M President and CEO sold 21% of stake
  3. Sabag Mark −$3.9M See "Remarks" sold 53% of stake
  4. Daniell Richard −$1.9M EVP, Europe Commercial sold 45% of stake
  5. Weiss Amir −$1.1M Chief Accounting Officer sold 88% of stake
Date Insider Transaction Shares Price Value Owned after
2018-03-12 Daniell Richard Exec. VP, European Commercial Sale −714 $19.50 $14K 0
2018-03-12 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −714 715
2018-03-05 O'Grady Brendan P. EVP, North America Commercial Shares withheld for taxes −461 $19.38 $9K 2,093.49
2018-03-05 O'Grady Brendan P. EVP, North America Commercial Sale −705 $19.38 $14K 1,388.49
2018-03-05 Nazzi Gianfranco EVP, Growth Markets Commercial Shares withheld for taxes −732 $19.28 $14K 4,912.36
2018-03-05 McClellan Michael James EVP, Chief Financial Officer Shares withheld for taxes −455 $19.38 $9K 10,922.27
2018-03-05 Griffin Deborah A Chief Accounting Officer Shares withheld for taxes −393 $19.38 $8K 773
2018-03-05 Griffin Deborah A Chief Accounting Officer Sale −773 $19.38 $15K 0
2018-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +3,432 7,941.51
2018-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Shares withheld for taxes −400 $19.38 $8K 7,541.51
2018-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Shares withheld for taxes −1,155 $19.38 $22K 6,386.51
2018-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −3,432 0
2018-03-05 Dethlefs Sven EVP Global Marketing&Portfolio Shares withheld for taxes −677 $19.38 $13K 3,222.7
2018-03-05 Daniell Richard Exec. VP, European Commercial Shares withheld for taxes −990 $19.28 $19K 1,108
2018-03-05 Daniell Richard Exec. VP, European Commercial Sale −1,108 $19.28 $21K 0
2018-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +1,165 4,509.51
2018-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −1,165 1,165
2018-03-03 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,166 2,554.49
2018-03-03 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −1,166 3,498
2018-03-03 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise +1,399 5,644.36

Page 74 of 76 · 1,517 trades